Treace Medical Concepts (TMCI) Change in Accured Expenses (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Change in Accured Expenses data on file, last reported at -$3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 49.3% year-over-year to -$3.1 million; the trailing twelve-month figure through Mar 2026 stood at $627000.0 (up 108.77% YoY), and the FY2025 full-year result was -$2.4 million, up 69.47% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$3.1 million, down from $778000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $9.5 million in Q4 2023 and bottomed at -$6.9 million in Q1 2024.
• The 5-year median for Change in Accured Expenses is $939000.0 (2023), against an average of $71235.3.
• The widest annual swing landed in 2022, when Change in Accured Expenses surged 192.95%; it then slumped 675.66% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $6.9 million in 2022, then jumped by 37.36% to $9.5 million in 2023, then plunged by 48.85% to $4.8 million in 2024, then plunged by 83.96% to $778000.0 in 2025, then sank by 501.8% to -$3.1 million in 2026.
• The last three Change in Accured Expenses figures came in at -$3.1 million (Q1 2026), $778000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.

Peer Comparison